{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:32:12Z","timestamp":1783031532850,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.intimp.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T06:57:34Z","timestamp":1523257054000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle"],"prefix":"10.1016","volume":"59","author":[{"given":"H.","family":"Noormehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zavaran Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Soudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Beyzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2018.03.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2018.03.012_bb0010","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.168.5.1675","article-title":"Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens","volume":"168","author":"Scott","year":"1988","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2018.03.012_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2018.03.012_bb0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI72058","article-title":"Collective nitric oxide production provides tissue-wide immunity during Leishmania infection","volume":"124","author":"Olekhnovitch","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2018.03.012_bb0025","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.4049\/jimmunol.145.12.4290","article-title":"Leishmania major amastigotes initiate the l-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha","volume":"145","author":"Green","year":"1990","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2018.03.012_bb0030","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.01335-06","article-title":"Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice","volume":"75","author":"Rocha","year":"2007","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.intimp.2018.03.012_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2018.03.012_bb0040","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2018.03.012_bb0045","first-page":"S53","article-title":"Management of visceral leishmaniasis: Indian perspective","volume":"51","author":"Agrawal","year":"2005","journal-title":"J. Postgrad. Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.03.012_bb0050","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic","volume":"49","author":"Srivastava","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.intimp.2018.03.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Trans. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2018.03.012_bb0060","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.intimp.2018.03.012_bb0065","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2018.03.012_bb0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"Lu","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"12","key":"10.1016\/j.intimp.2018.03.012_bb0075","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.22709","article-title":"Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles","volume":"120","author":"Liu","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2018.03.012_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.exppara.2012.04.017","article-title":"Poly d,l-lactide-co-glycolic acid (PLGA)-encapsulated vaccine on immune system in Epinephelus bruneus against Uronema marinum","volume":"131","author":"Harikrishnan","year":"2012","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.intimp.2018.03.012_bb0085","first-page":"71","article-title":"Alpha alumina nanoparticle conjugation to cysteine peptidase A and B: an efficient method for autophagy induction","volume":"9","author":"Beyzay","year":"2017","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2018.03.012_bb0090","first-page":"271","article-title":"Intravenous injection of myelin oligodendrocyte glycoprotein-coated PLGA microparticles have tolerogenic effects in experimental autoimmune encephalomyelitis","volume":"16","author":"Gholamzad","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2018.03.012_bb0095","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2018.03.012_bb0100","doi-asserted-by":"crossref","first-page":"p2764","DOI":"10.1002\/jcb.25926","article-title":"Pretreatment of mesenchymal stem cells with Leishmania major soluble antigens induce anti-inflammatory properties in mouse peritoneal macrophages","volume":"118","author":"Khosrowpour","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2018.03.012_bb0105","first-page":"639","article-title":"Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins","volume":"27","author":"Tafaghodi","year":"2010","journal-title":"Trop. Biomed."},{"issue":"1","key":"10.1016\/j.intimp.2018.03.012_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-6851(00)00377-7","article-title":"Identification of Leishmania major cysteine proteinases as targets of the immune response in humans","volume":"113","author":"Rafati","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"issue":"16","key":"10.1016\/j.intimp.2018.03.012_bb0115","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leshmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2018.03.012_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2018.03.012_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2004.09.014","article-title":"Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery","volume":"102","author":"Chong","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2018.03.012_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNF\u03b1 mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"Margaroni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2018.03.012_bb0135","first-page":"2115","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.intimp.2018.03.012_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exppara.2013.07.008","article-title":"Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice","volume":"135","author":"de Carvalho","year":"2013","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.intimp.2018.03.012_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exppara.2006.07.002","article-title":"Leishmania major: immune response in BALB\/c mice immunized with stress-inducible protein 1 encapsulated in liposomes","volume":"115","author":"Badiee","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.intimp.2018.03.012_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00436-011-2806-5","article-title":"Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis","volume":"111","author":"Heravi Shargh","year":"2012","journal-title":"Parasitol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918301140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:12Z","timestamp":1761585012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918301140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"alternative-id":["S1567576918301140"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.03.012","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}